Downregulation of Krüppel-like factor 5 can inhibit hypoxia-induced cisplatin resistance in non-small-cell lung cancer, and its mechanism is via the inhibition of HIF-1α-dependent glycolysis through the inactivation of the PI3K/AKT/mTOR pathway (182). Here, AKT1 is linked to non-small cell lung carcinoma.